This inventor holds 1 USPTO granted patent. Top assignee: Beijing Normal University. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Chuanmin Qi: Innovator in Tumor Targeted Therapy
Introduction
Chuanmin Qi is a prominent inventor based in Beijing, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for tumor targeted therapy. His innovative work has the potential to impact the treatment of tumors and related diseases.
Latest Patents
Chuanmin Qi holds a patent for a compound titled "Quinazolines compound, preparation method therefor and application thereof." This invention discloses a compound of anilino polyethylene glycol ether cycloquinazoline, which is substituted with a substituted arylmethyl heteroatomic group. The patent also covers pharmaceutically acceptable salts, esters, or solvates of the compound, along with a pharmaceutical composition that includes the same. The disclosed compound and composition can be utilized in tumor targeted therapy and in the regulation of tumors and related diseases. He has 1 patent to his name.
Career Highlights
Chuanmin Qi is affiliated with Beijing Normal University, where he continues to engage in research and development in the pharmaceutical sciences. His work at the university allows him to collaborate with other researchers and contribute to advancements in medical treatments.
Collaborations
Due to space constraints, the details of Chuanmin Qi's collaborations will not be included.
Conclusion
Chuanmin Qi's innovative contributions to tumor targeted therapy highlight his role as a significant inventor in the pharmaceutical field. His work has the potential to lead to advancements in the treatment of tumors and related diseases.